Sexually Transmitted Diseases (STD) Testing Market, Global Outlook and Forecast 2023-2029

Report ID: MMG206189 | Category: Medical Care | Pages: 61 | Format: PDF | Published Date: September 05,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

Sexually Transmitted Diseases (STD) Testing is used to detect all kinds of Sexually Transmitted virus.Sexually transmitted diseases are considered as one of the most critical health challenges globally. Chlamydia, gonorrhea, and herpes simplex virus are some of the highly prevalent sexually transmitted diseases.
This report aims to provide a comprehensive presentation of the global market for Sexually Transmitted Diseases (STD) Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sexually Transmitted Diseases (STD) Testing. This report contains market size and forecasts of Sexually Transmitted Diseases (STD) Testing in global, including the following market information:
Global Sexually Transmitted Diseases (STD) Testing Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Sexually Transmitted Diseases (STD) Testing market was valued at US$ 80720 million in 2022 and is projected to reach US$ 99700 million by 2029, at a CAGR of 3.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Chlamydia Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Sexually Transmitted Diseases (STD) Testing include ROCHE HOLDINGS, BIOMERIEUX, HOLOGIC, BECTON DICKINSON, ORASURE, DANAHER, AFFYMETRIX, ABBOTT LABORATORIES and BIO-RAD LABORATORIES, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Sexually Transmitted Diseases (STD) Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sexually Transmitted Diseases (STD) Testing Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Sexually Transmitted Diseases (STD) Testing Market Segment Percentages, by Type, 2022 (%)
    Chlamydia
    Syphilis
    Gonorrhea
    Herpes Simplex Virus
    Human Papilloma Virus
    Human Immunodeficiency Virus
    Others
Global Sexually Transmitted Diseases (STD) Testing Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Sexually Transmitted Diseases (STD) Testing Market Segment Percentages, by Application, 2022 (%)
    Laboratory Testing
    Point of Care (POC) Testing
Global Sexually Transmitted Diseases (STD) Testing Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Sexually Transmitted Diseases (STD) Testing Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sexually Transmitted Diseases (STD) Testing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Sexually Transmitted Diseases (STD) Testing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    ROCHE HOLDINGS
    BIOMERIEUX
    HOLOGIC
    BECTON DICKINSON
    ORASURE
    DANAHER
    AFFYMETRIX
    ABBOTT LABORATORIES
    BIO-RAD LABORATORIES
    DIASORIN
Outline of Major Chapters:
Chapter 1: Introduces the definition of Sexually Transmitted Diseases (STD) Testing, market overview.
Chapter 2: Global Sexually Transmitted Diseases (STD) Testing market size in revenue.
Chapter 3: Detailed analysis of Sexually Transmitted Diseases (STD) Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Sexually Transmitted Diseases (STD) Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Sexually Transmitted Diseases (STD) Testing Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Sexually Transmitted Diseases (STD) Testing Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Sexually Transmitted Diseases (STD) Testing Overall Market Size
    2.1 Global Sexually Transmitted Diseases (STD) Testing Market Size: 2022 VS 2029
    2.2 Global Sexually Transmitted Diseases (STD) Testing Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Sexually Transmitted Diseases (STD) Testing Players in Global Market
    3.2 Top Global Sexually Transmitted Diseases (STD) Testing Companies Ranked by Revenue
    3.3 Global Sexually Transmitted Diseases (STD) Testing Revenue by Companies
    3.4 Top 3 and Top 5 Sexually Transmitted Diseases (STD) Testing Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Sexually Transmitted Diseases (STD) Testing Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Sexually Transmitted Diseases (STD) Testing Players in Global Market
        3.6.1 List of Global Tier 1 Sexually Transmitted Diseases (STD) Testing Companies
        3.6.2 List of Global Tier 2 and Tier 3 Sexually Transmitted Diseases (STD) Testing Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Sexually Transmitted Diseases (STD) Testing Market Size Markets, 2022 & 2029
        4.1.2 Chlamydia
        4.1.3 Syphilis
        4.1.4 Gonorrhea
        4.1.5 Herpes Simplex Virus
        4.1.6 Human Papilloma Virus
        4.1.7 Human Immunodeficiency Virus
        4.1.8 Others
    4.2 By Type - Global Sexually Transmitted Diseases (STD) Testing Revenue & Forecasts
        4.2.1 By Type - Global Sexually Transmitted Diseases (STD) Testing Revenue, 2018-2023
        4.2.2 By Type - Global Sexually Transmitted Diseases (STD) Testing Revenue, 2024-2029
        4.2.3 By Type - Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Sexually Transmitted Diseases (STD) Testing Market Size, 2022 & 2029
        5.1.2 Laboratory Testing
        5.1.3 Point of Care (POC) Testing
    5.2 By Application - Global Sexually Transmitted Diseases (STD) Testing Revenue & Forecasts
        5.2.1 By Application - Global Sexually Transmitted Diseases (STD) Testing Revenue, 2018-2023
        5.2.2 By Application - Global Sexually Transmitted Diseases (STD) Testing Revenue, 2024-2029
        5.2.3 By Application - Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Sexually Transmitted Diseases (STD) Testing Market Size, 2022 & 2029
    6.2 By Region - Global Sexually Transmitted Diseases (STD) Testing Revenue & Forecasts
        6.2.1 By Region - Global Sexually Transmitted Diseases (STD) Testing Revenue, 2018-2023
        6.2.2 By Region - Global Sexually Transmitted Diseases (STD) Testing Revenue, 2024-2029
        6.2.3 By Region - Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Sexually Transmitted Diseases (STD) Testing Revenue, 2018-2029
        6.3.2 US Sexually Transmitted Diseases (STD) Testing Market Size, 2018-2029
        6.3.3 Canada Sexually Transmitted Diseases (STD) Testing Market Size, 2018-2029
        6.3.4 Mexico Sexually Transmitted Diseases (STD) Testing Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Sexually Transmitted Diseases (STD) Testing Revenue, 2018-2029
        6.4.2 Germany Sexually Transmitted Diseases (STD) Testing Market Size, 2018-2029
        6.4.3 France Sexually Transmitted Diseases (STD) Testing Market Size, 2018-2029
        6.4.4 U.K. Sexually Transmitted Diseases (STD) Testing Market Size, 2018-2029
        6.4.5 Italy Sexually Transmitted Diseases (STD) Testing Market Size, 2018-2029
        6.4.6 Russia Sexually Transmitted Diseases (STD) Testing Market Size, 2018-2029
        6.4.7 Nordic Countries Sexually Transmitted Diseases (STD) Testing Market Size, 2018-2029
        6.4.8 Benelux Sexually Transmitted Diseases (STD) Testing Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Sexually Transmitted Diseases (STD) Testing Revenue, 2018-2029
        6.5.2 China Sexually Transmitted Diseases (STD) Testing Market Size, 2018-2029
        6.5.3 Japan Sexually Transmitted Diseases (STD) Testing Market Size, 2018-2029
        6.5.4 South Korea Sexually Transmitted Diseases (STD) Testing Market Size, 2018-2029
        6.5.5 Southeast Asia Sexually Transmitted Diseases (STD) Testing Market Size, 2018-2029
        6.5.6 India Sexually Transmitted Diseases (STD) Testing Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Sexually Transmitted Diseases (STD) Testing Revenue, 2018-2029
        6.6.2 Brazil Sexually Transmitted Diseases (STD) Testing Market Size, 2018-2029
        6.6.3 Argentina Sexually Transmitted Diseases (STD) Testing Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Sexually Transmitted Diseases (STD) Testing Revenue, 2018-2029
        6.7.2 Turkey Sexually Transmitted Diseases (STD) Testing Market Size, 2018-2029
        6.7.3 Israel Sexually Transmitted Diseases (STD) Testing Market Size, 2018-2029
        6.7.4 Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market Size, 2018-2029
        6.7.5 UAE Sexually Transmitted Diseases (STD) Testing Market Size, 2018-2029
7 Sexually Transmitted Diseases (STD) Testing Companies Profiles
    7.1 ROCHE HOLDINGS
        7.1.1 ROCHE HOLDINGS Company Summary
        7.1.2 ROCHE HOLDINGS Business Overview
        7.1.3 ROCHE HOLDINGS Sexually Transmitted Diseases (STD) Testing Major Product Offerings
        7.1.4 ROCHE HOLDINGS Sexually Transmitted Diseases (STD) Testing Revenue in Global Market (2018-2023)
        7.1.5 ROCHE HOLDINGS Key News & Latest Developments
    7.2 BIOMERIEUX
        7.2.1 BIOMERIEUX Company Summary
        7.2.2 BIOMERIEUX Business Overview
        7.2.3 BIOMERIEUX Sexually Transmitted Diseases (STD) Testing Major Product Offerings
        7.2.4 BIOMERIEUX Sexually Transmitted Diseases (STD) Testing Revenue in Global Market (2018-2023)
        7.2.5 BIOMERIEUX Key News & Latest Developments
    7.3 HOLOGIC
        7.3.1 HOLOGIC Company Summary
        7.3.2 HOLOGIC Business Overview
        7.3.3 HOLOGIC Sexually Transmitted Diseases (STD) Testing Major Product Offerings
        7.3.4 HOLOGIC Sexually Transmitted Diseases (STD) Testing Revenue in Global Market (2018-2023)
        7.3.5 HOLOGIC Key News & Latest Developments
    7.4 BECTON DICKINSON
        7.4.1 BECTON DICKINSON Company Summary
        7.4.2 BECTON DICKINSON Business Overview
        7.4.3 BECTON DICKINSON Sexually Transmitted Diseases (STD) Testing Major Product Offerings
        7.4.4 BECTON DICKINSON Sexually Transmitted Diseases (STD) Testing Revenue in Global Market (2018-2023)
        7.4.5 BECTON DICKINSON Key News & Latest Developments
    7.5 ORASURE
        7.5.1 ORASURE Company Summary
        7.5.2 ORASURE Business Overview
        7.5.3 ORASURE Sexually Transmitted Diseases (STD) Testing Major Product Offerings
        7.5.4 ORASURE Sexually Transmitted Diseases (STD) Testing Revenue in Global Market (2018-2023)
        7.5.5 ORASURE Key News & Latest Developments
    7.6 DANAHER
        7.6.1 DANAHER Company Summary
        7.6.2 DANAHER Business Overview
        7.6.3 DANAHER Sexually Transmitted Diseases (STD) Testing Major Product Offerings
        7.6.4 DANAHER Sexually Transmitted Diseases (STD) Testing Revenue in Global Market (2018-2023)
        7.6.5 DANAHER Key News & Latest Developments
    7.7 AFFYMETRIX
        7.7.1 AFFYMETRIX Company Summary
        7.7.2 AFFYMETRIX Business Overview
        7.7.3 AFFYMETRIX Sexually Transmitted Diseases (STD) Testing Major Product Offerings
        7.7.4 AFFYMETRIX Sexually Transmitted Diseases (STD) Testing Revenue in Global Market (2018-2023)
        7.7.5 AFFYMETRIX Key News & Latest Developments
    7.8 ABBOTT LABORATORIES
        7.8.1 ABBOTT LABORATORIES Company Summary
        7.8.2 ABBOTT LABORATORIES Business Overview
        7.8.3 ABBOTT LABORATORIES Sexually Transmitted Diseases (STD) Testing Major Product Offerings
        7.8.4 ABBOTT LABORATORIES Sexually Transmitted Diseases (STD) Testing Revenue in Global Market (2018-2023)
        7.8.5 ABBOTT LABORATORIES Key News & Latest Developments
    7.9 BIO-RAD LABORATORIES
        7.9.1 BIO-RAD LABORATORIES Company Summary
        7.9.2 BIO-RAD LABORATORIES Business Overview
        7.9.3 BIO-RAD LABORATORIES Sexually Transmitted Diseases (STD) Testing Major Product Offerings
        7.9.4 BIO-RAD LABORATORIES Sexually Transmitted Diseases (STD) Testing Revenue in Global Market (2018-2023)
        7.9.5 BIO-RAD LABORATORIES Key News & Latest Developments
    7.10 DIASORIN
        7.10.1 DIASORIN Company Summary
        7.10.2 DIASORIN Business Overview
        7.10.3 DIASORIN Sexually Transmitted Diseases (STD) Testing Major Product Offerings
        7.10.4 DIASORIN Sexually Transmitted Diseases (STD) Testing Revenue in Global Market (2018-2023)
        7.10.5 DIASORIN Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Sexually Transmitted Diseases (STD) Testing Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?